OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Antiretroviral Therapy

Antiretroviral Therapy


As per available reports about 02 through its relevant journals, 09 Conferences, 08 workshopsare presently dedicated exclusively to Antiretroviral Therapy and about 93 articles are being published on Antiretroviral Therapy.

ARV, drugs are chosen on the basis of treatment guidelines, HIV drug resistance, your health (for example, kidney or liver disease) and lifestyle factors. While ARV regimens are usually well tolerated, each ARV drug can have side effects. Some may be serious. Refer to the fact sheet for each individual drug. Each person is different, and you and your health care provider will have to decide which drugs to use. Adherence to ARVs is very important for treatment to work. The viral load test is used to see if ARV drugs are working.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

There are treatments for HIV that can control the virus and help you stay healthy. Treatment can help people at any stage of HIV disease, even AIDS, but it is NOT a cure. The medications are called either Highly Active Antiretroviral Therapy (HAART) or Active Antiretroviral Therapy (ART). The use of less than three active agents is not recommended for initiating treatment. These agents belong to six distinct classes of drugs the nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs, NtRTIs), the non-nucleoside reverse transcriptase inhibitors (NNRTIs), the protease inhibitors (PIs), the fusion inhibitors (FIs), the CCR5 co-receptor antagonists, and the integrase strand transfer inhibitors (INSTIs).

ART are medications that treat HIV. The drugs do not kill or cure the virus. However, when taken in combination they can prevent the growth of the virus. When the virus is slowed down, so is HIV disease. Antiretroviral drugs are referred to as ARV. Combination ARV therapy (cART) is referred to as highly active ART (HAART). Antiretroviral drugs are usually used in combinations of three or more drugs from more than one class. This is called "Combination Therapy." Combination therapy helps prevent drug resistance. Manufacturers of ARVs keep trying to make their drugs easier to take, and have combined some of them into a single tablet regimen. In word ARVs reduce the viral load, the amount of virus in your bloodstream, but are not a cure. A blood test measures the viral load. People with undetectable viral loads stay healthier longer. They are also less likely to transmit HIV infection to others.Some people’s viral load is so low that it is “undetectable” by the viral load test. This does not mean that all the virus is gone, and it does not mean a person is cured of HIV infection.
 

Market Analysis:
The market for breathing disorder The most recent estimate we've found of drug costs comes from The Global Fund to Fight Aids, Tuberculosis and Malaria, which reports median expenditures on drugs of $188 per person per year of first-line ART drugs, and $588 per person per year for all ART program costs across its large, broad global project portfolio. In 2007, the cost of a year's worth of ART was $299 for first-line drugs and $709 for second-line drugs. The Disease Control Priorities Report estimates that ART costs $350-$1,494 per disability-adjusted life-year (DALY) averted in Sub-Saharan Africa. This is equivalent (from a simple conversion calculation)27 to $129.50-$552.78 per year spent on ART

International symposium and workshops:

  • 10th International Workshop on HIV Transmission - Principles of Intervention, to be held in Atlanta, GA, USA on December 5-6, 2015
  • 22nd International Symposium on Hepatitis C Virus and Related Viruses - October 9-13, 2015
  • 28th International Conference on Antiviral Research (ICAR), May 11th, 2015, Rome Italy
  • Palm Springs Symposium on HIV/AIDS, March 3-5, 2016 Palm Springs, California

List of Best International Conferences :

Relevant Society and Associations:

  • International Association of Providers of AIDS Care (IAPAC).London
  • International Antiviral Society–USA
  • International AIDS Society, USA
  • British HIV Association
  • International Association of Providers of AIDS Care (IAPAC).London
  • International Antiviral Society–USA
  • International AIDS Society, USA
  • International Society for Antiviral Research.
  • International Antivirals and Vaccines Society.
  • International Society for Influenza and Other Respiratory Virus Disease.
  • Society for Clinical Trials (SCT)
  • Stanford Genomic Resources
  • The United States Pharmacopeia (USP)
  • National Science Foundation (NSF)
  • Federal Laboratory Consortium for Technology Transfer
  • The Society for Medicines Research
  • Royal Society of Chemistry
  • Alzheimer's Drug Discovery Foundation
  • American Association of Pharmaceutical Scientists


Companies:

  • GlaxoSmithKline (GSK), USA
  • Merck, USA
  • Cipla, India
  • Ranbaxy, India
  • Hetero, India
  • Big Pharma
  • Gilead Sciences, USA
  • Bristol Myers-Squibb , USA
  • Tibotec Therapeutics, USA
  • Pfizer, USA
  • Abbott Laboratories, USA
  • Johnson & Johnson
  • Novartis
  • Roche
  • Sanofi
  • Bayer HealthCare
  • AstraZeneca
  • Eli Lilly
  • Cell Biologyare Lancaster Laboratories
  • Millennium Pharmaceuticals Inc
  • PrioBio
  • Array BioPharma
  • Origene
  • Alexion Pharmaceuticals
  • ImmunoGen Inc

List of Journals:

  • Journal of AIDS & Clinical Research
  • Journal of Clinical & Cellular Immunology
  • Journal of Antivirals & Antiretrovirals
  • Journal of Infectious Diseases & Therapy
  • Virology & Mycology

This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising